No additional benefit of HRT on response to rivastigmine in menopausal women with AD

Neurology

Volumn 60, Issue 1, 2003, Pages 148-150

  Rigaud, A S ^a   Andre G ^b   Vellas, B ^c   Touchon, J ^d   Pere, J J ^e  

^a Paris Descartes University   (France)

^b Department of Gynecology ^*  (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d CHU PURPAN   (France)

^e NOVARTIS PHARMA K K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PLACEBO; PROGESTERONE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BREAST TENSION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUATION DISORDER; METRORRHAGIA; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0037435541     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.60.1.148-a     Document Type: Article

References (6)

1. Corey-Bloom J, Anand R, Veach J. A randomized trial evaluating the efficacy and safety of rivastigmine tartrate, a new acetylcholinesterase inhibitor in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol 1998;1:55-65.
2. Schneider LS, Farlow MR, Henderson VW, et al. Effects of estrogen replacement therapy on response to tacrine inpatients with Alzheimer's disease. Neurology 1996;46:1580-1584.
3. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women. Randomized, double blind, placebo-controlled trial. Neurology 2000;54:295-301.
4. Mulnard RA, Cotman CW, Kawas C, et al for the Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-1015.
5. Wang PN, Liao SQ, Liu RS, et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. A controlled study. Neurology 2000;54:2061-2066.
6. Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101:485-512.